Joe Tung, MD
Dermatology · Pittsburgh, PANPI 1871121509
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $298,082 of the $404,114 with a category attached, or 73.8%. It is spread thinly across 27 manufacturers, the largest accounting for just 20.8%. 2025 is the largest year on record at $357,849, more than ten times the $487 reported in 2021. Among dermatology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 530 payments — averaging $762.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$84K
- Johnson & Johnson$79K
- Lilly USA, LLC$66K
- UCB, Inc.$63K
- E.r. Squibb & Sons, L.L.C.$32K
- Sun Pharmaceutical Industries Inc.$22K
- plus $58K from 21 others
Across 103 payments — averaging $10,484 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$406K
- Takeda Pharmaceuticals U.S.A., Inc.$331K
- Sanofi US Services Inc.$122K
- UCB SA$97K
- Janssen Research & Development, LLC$47K
- Amgen$43K
- plus $34K from 4 others
What the payments were for
- Consulting fees$61,84515%
- Speaking & faculty fees$298,08274%
- Travel & lodging$26,8397%
- Food & beverage$17,0884%
- Education$2600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 95 | $84,005 |
| Johnson & Johnson(2 entities) | 86 | $78,984 |
| Lilly USA, LLC | 67 | $65,580 |
| UCB, Inc. | 68 | $63,041 |
| E.r. Squibb & Sons, L.L.C. | 36 | $32,470 |
| Sun Pharmaceutical Industries Inc. | 34 | $22,403 |
| LEO Pharma Inc. | 22 | $21,138 |
| Pfizer | 11 | $13,764 |
| Regeneron Healthcare Solutions, Inc. | 12 | $4,680 |
| Boehringer Ingelheim | 5 | $4,659 |
| Galderma Laboratories, L.p. | 9 | $3,637 |
| Journey Medical Corporation | 4 | $3,200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $2,099 |
| Arcutis Biotherapeutics, Inc. | 19 | $1,930 |
| Incyte Corporation | 7 | $608 |
| Dermavant Sciences, Inc. | 3 | $320 |
| Novartis | 15 | $317 |
| Sanofi | 4 | $234 |
| Amgen | 3 | $193 |
| Janssen Scientific Affairs, LLC | 5 | $131 |
| Nobelpharma America, LLC | 1 | $126 |
| Organon | 1 | $124 |
| Verrica Pharmaceuticals Inc. | 1 | $120 |
| Stemline Therapeutics Inc. | 1 | $101 |
| Kyowa Kirin, Inc. | 1 | $93 |
| Regeneron | 2 | $84 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $72 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$404,114 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 19 | $69,175 |
| Tacrolimus | 31 | $3,662 |
| Clobetasol Propionate | 63 | $1,914 |
| Ketoconazole | 88 | $1,352 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 11 | $804 |
| Fluorouracil | 13 | $670 |
| Triamcinolone Acetonide | 73 | $631 |
| MethotrexateMethotrexate Sodium | 15 | $251 |
| Doxycycline Hyclate | 12 | $146 |
| Hydrocortisone | 25 | $143 |
| Mupirocin | 17 | $88 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Pittsburgh
- Neil NirenPittsburgh$574K
- Laura FerrisPittsburgh$502K
- Oleg AkilovPittsburgh$409K
- Charles MountPittsburgh$189K
- Timothy PattonPittsburgh$72K
- Daniel KaplanPittsburgh$46K
- Hassane ZarourPittsburgh$44K
- Scott GottliebExton$2.1M
- Douglas KressWexford$2M
- Stephen HessPhiladelphia$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.